vs

Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and ELBIT SYSTEMS LTD (ESLT). Click either name above to swap in a different company.

BIOHARVEST SCIENCES INC. is the larger business by last-quarter revenue ($8.4M vs $5.8M, roughly 1.4× ELBIT SYSTEMS LTD).

BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.

Elbit Systems Ltd. is an Israel-based international military technology company and defense contractor. Founded in 1966 by Elron, Elbit Systems is the primary provider of the Israeli military's land-based equipment and unmanned aerial vehicles. It is an important company within the defense industry of Israel.

BHST vs ESLT — Head-to-Head

Bigger by revenue
BHST
BHST
1.4× larger
BHST
$8.4M
$5.8M
ESLT

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
BHST
BHST
ESLT
ESLT
Revenue
$8.4M
$5.8M
Net Profit
$367.1K
Gross Margin
60.3%
24.3%
Operating Margin
8.3%
Net Margin
6.3%
Revenue YoY
Net Profit YoY
EPS (diluted)
$7.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHST
BHST
ESLT
ESLT
Q3 25
$8.4M
$5.8M
Q2 25
$8.1M
Q1 25
$7.7M
Q3 24
$6.5M
Q2 24
$6.0M
Net Profit
BHST
BHST
ESLT
ESLT
Q3 25
$367.1K
Q2 25
Q1 25
Q3 24
Q2 24
Gross Margin
BHST
BHST
ESLT
ESLT
Q3 25
60.3%
24.3%
Q2 25
60.0%
Q1 25
58.2%
Q3 24
Q2 24
Operating Margin
BHST
BHST
ESLT
ESLT
Q3 25
8.3%
Q2 25
Q1 25
Q3 24
Q2 24
Net Margin
BHST
BHST
ESLT
ESLT
Q3 25
6.3%
Q2 25
Q1 25
Q3 24
Q2 24
EPS (diluted)
BHST
BHST
ESLT
ESLT
Q3 25
$7.85
Q2 25
Q1 25
Q3 24
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHST
BHST
ESLT
ESLT
Cash + ST InvestmentsLiquidity on hand
$265.4K
Total DebtLower is stronger
$90.7K
Stockholders' EquityBook value
$3.3M
Total Assets
$11.0M
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHST
BHST
ESLT
ESLT
Q3 25
$265.4K
Q2 25
Q1 25
Q3 24
Q2 24
Total Debt
BHST
BHST
ESLT
ESLT
Q3 25
$90.7K
Q2 25
Q1 25
Q3 24
Q2 24
Stockholders' Equity
BHST
BHST
ESLT
ESLT
Q3 25
$3.3M
Q2 25
Q1 25
Q3 24
Q2 24
Total Assets
BHST
BHST
ESLT
ESLT
Q3 25
$11.0M
Q2 25
Q1 25
Q3 24
Q2 24
Debt / Equity
BHST
BHST
ESLT
ESLT
Q3 25
0.03×
Q2 25
Q1 25
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHST
BHST
ESLT
ESLT
Operating Cash FlowLast quarter
$534.6K
Free Cash FlowOCF − Capex
$319.6K
FCF MarginFCF / Revenue
5.5%
Capex IntensityCapex / Revenue
3.7%
Cash ConversionOCF / Net Profit
1.46×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHST
BHST
ESLT
ESLT
Q3 25
$534.6K
Q2 25
Q1 25
Q3 24
Q2 24
Free Cash Flow
BHST
BHST
ESLT
ESLT
Q3 25
$319.6K
Q2 25
Q1 25
Q3 24
Q2 24
FCF Margin
BHST
BHST
ESLT
ESLT
Q3 25
5.5%
Q2 25
Q1 25
Q3 24
Q2 24
Capex Intensity
BHST
BHST
ESLT
ESLT
Q3 25
3.7%
Q2 25
Q1 25
Q3 24
Q2 24
Cash Conversion
BHST
BHST
ESLT
ESLT
Q3 25
1.46×
Q2 25
Q1 25
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons